semaglutide for parkinson's GLP-1 drug shows little benefit people with disease | UCL News Frontiers | Neuroprotective effects of

Draw desired solvent amount into syringe Open solvent vial

And, while this particular side effect also appears rare, an association is being established in studies of patients taking GLP-1 receptor agonists

However, your doctor will monitor your progress and discuss how long you may need to receive treatment

[ Links ] Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden CD (1994) Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

That said, some customer complaints exist on third-party platforms (detailed above), and this article did not independently investigate those specific claims